Media Release IMP761 is designed to enhance the “brake” function of LAG-3 on T cells to restore balance to the…
Expects to report topline results in 2025 from Phase 2a influenza A human challenge study with oral CC-42344, including initial…
Denifanstat Phase 2b FASCINATE-2 clinical trial 52-week data was presented in June at the European Association for the Study of…
Dr. Capon will present Hinge Bio’s innovative GEM-DIMER™ platform as an invited speaker at the “Pioneering Technology” Session at Trinity College,…
Company Anticipates Significant Sequential Growth in Quarterly Revenues Beginning in Q3 2024 and Beyond Reports Pharmaloz Growth Acceleration Has Begun…
LOS ANGELES, Aug. 14, 2024 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of Greyhound Chromatography and…
– Topline data from 1-year open-label extension (OLE) trial expected Q4 2024 – – Registrational RECOVER-2 trial in schizophrenia expected to…
- Reports YCANTH® revenue, net of $4.9M for second quarter of 2024 along with the expansion of YCANTH’s distribution footprint…
California Bars and Clubs Are Now Mandated to Offer Date Rape Drug Test KitsSafety Strips is First to Achieve Mass-Scale…
Regulatory milestone validates the SOPHiA DDM™ Platform as diagnostic tool in select markets BOSTON and ROLLE, Switzerland, Aug. 14, 2024 /PRNewswire/…